VRTX fundamentals
An in-depth look to Vertex Pharmaceuticals Incorporated operating, investing, and financing activities
VRTX free cash flow for Q4 23 is 176.5 M USD. For 2023, VRTX free cash flow was 3.34 B USD and operating cash flow was 3.54 B USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM